On the part of trenbolone enanthate gains hematopoiesis: lymphocytopenia, eosinophilia, leukopenia, thrombocytopenia, transient neutropenia, hemolytic anemia. From the nervous system: dizziness, vertigo, drowsiness, headache, convulsions, paraesthesia, gipostezii, asthenia, insomnia, hyperactivity, aggression, anxiety , anxiety, nervousness. From the senses: hearing loss, deafness, tinnitus, taste perversion or smell, decreased visual acuity. cardio-vascular system: palpitations, arrhythmia (including ventricular tachycardia, torsades de pointes ), prolongation of the interval .
From the digestive system: nausea, vomiting, diarrhea, abdominal pain or cramps, unformed stools, flatulence, indigestion, gastritis, anorexia, constipation, change the language of color, pseudomembranous colitis, hepatitis, cholestatic jaundice, violation of liver function tests, liver necrosis and hepatic failure (including death). From the musculoskeletal system: . arthralgia From the urogenital system: vaginitis, interstitial nephritis, acute renal failure. Allergic reactions: itching and rash, angioedema, rash, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, anaphylactic reactions. Laboratory indicators: increase in serum concentrations of bilirubin, urea, creatinine, potassium ions, reduced serum concentrations of bicarbonate. Other: candidiasis, chest pain , edema, syncope, exacerbation of myasthenia gravis.
Symptoms: temporary hearing loss, nausea and vomiting, diarrhea.
Treatment: reception activated carbon, maintenance of the vital functions of the body.
Interaction with other medicinal products
Antacids reduce the maximum concentration of azithromycin at 30%, so azithromycin should be taken 1 hour before or 2 hours after taking antacids.
At simultaneous application with cyclosporine should monitor the concentration of cyclosporine in the blood.
In an application with indirect anticoagulants may increase the frequency of bleeding, should monitor the prothrombin time and international normalized ratio trenbolone enanthate gains.
in an application with digoxin may increase in the blood concentration of the latter, so you should monitor the concentration of digoxin in the blood.
while the use of ergotamine ergotism may develop; concurrent use is not recommended.
Concomitant use of macrolides and theophylline in some cases has led to an increase in the concentration of the latter.
Azithromycin increases the content zidovudintrifosfata (the active metabolite of zidovudine) in mononuclear cells, the clinical significance of this phenomenon is unknown.
Concomitant use of rifabutin can cause neutropenia.
In simultaneous reception fluconazole reduce azithromycin maximum concentration of 18%.
in the case of missing a single dose of the drug – the missed dose should be taken as soon as possible, and follow – at intervals of 24 hours.
When pharyngitis and tonsillitis caused by pyogenes, selection antibiotics are penicillins. Efficacy of azithromycin for the prevention of rheumatic fever is unknown.
In the application of azithromycin, as well as the use of other antibiotics there is a risk of superinfection (including fungal).
Chronic administration of azithromycin may develop pseudomembranous colitis of Clostridium difficile- . With the development of diarrhea in patients receiving azithromycin and 2 months after completion of therapy should be excluded clostridial pseudomembranous colitis.
Effects on ability to drive vehicles and use machines
In the case of adverse reactions of the trenbolone enanthate gains nervous system, patients are advised to refrain from driving and other mechanisms, as well as to be careful during the occupation activities that require high concentration and speed of psychomotor reactions.
biomex geneza pharmaceuticals steroids mexico pharmacy steroid